RVMD REVOLUTION MEDICINES INC More: the full row for REVOLUTION MEDICINES INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 465,000 shares; 2025Q2: 636,835 shares; 2025Q3: 1,064,249 shares; 2025Q4: 1,283,900 shares; 2026Q1: 1,652,808 shares; 2026Q2: 1,961,795 shares; 2026Q3: 1,961,795 shares 1,961,795 $403M 24.64% 0 Timeline LQDA LIQUIDIA CORPORATION More: the full row for LIQUIDIA CORPORATION Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 8,118,592 shares; 2025Q1: 8,118,592 shares; 2025Q2: 8,118,892 shares; 2025Q3: 8,118,892 shares; 2025Q4: 8,118,892 shares; 2026Q1: 8,118,892 shares; 2026Q2: 8,118,892 shares; 2026Q3: 8,118,892 shares 8,118,892 $246M 15.03% 0 Timeline ABVX ABIVAX SA More: the full row for ABIVAX SA Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 752,167 shares; 2025Q1: 1,269,119 shares; 2025Q2: 1,674,400 shares; 2025Q3: 1,451,924 shares; 2025Q4: 1,451,924 shares; 2026Q1: 1,461,924 shares; 2026Q2: 1,557,924 shares; 2026Q3: 1,557,924 shares 1,557,924 $154M 9.44% 0 Timeline PCVX VAXCYTE INC More: the full row for VAXCYTE INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 1,704,815 shares; 2026Q1: 2,060,719 shares; 2026Q2: 2,188,636 shares; 2026Q3: 2,188,636 shares 2,188,636 $125M 7.62% 0 Timeline EXEL EXELIXIS INC More: the full row for EXELIXIS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,525,730 shares; 2025Q1: 1,525,730 shares; 2025Q2: 1,525,730 shares; 2025Q3: 1,525,730 shares; 2025Q4: 1,553,262 shares; 2026Q1: 1,553,262 shares; 2026Q2: 1,553,262 shares; 2026Q3: 1,553,262 shares 1,553,262 $90.7M 5.55% 0 Timeline TNGX TANGO THERAPEUTICS INC More: the full row for TANGO THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 3,729,895 shares; 2026Q1: 2,408,798 shares; 2026Q2: 2,500,103 shares; 2026Q3: 2,501,246 shares 2,501,246 $62.4M 3.82% +1,143 Timeline ADMA ADMA BIOLOGICS INC More: the full row for ADMA BIOLOGICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 2,636,609 shares; 2025Q4: 3,012,508 shares; 2026Q1: 4,756,511 shares; 2026Q2: 5,725,007 shares; 2026Q3: 5,875,007 shares 5,875,007 $58.9M 3.61% +150,000 Timeline IMCR IMMUNOCORE HLDGS PLC More: the full row for IMMUNOCORE HLDGS PLC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 1,381,317 shares; 2026Q3: 1,672,141 shares 1,672,141 $50.6M 3.1% +290,824 Timeline AVTX AVALO THERAPEUTICS INC More: the full row for AVALO THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 833,333 shares; 2025Q4: 881,533 shares; 2026Q1: 1,635,023 shares; 2026Q2: 3,163,866 shares; 2026Q3: 3,268,303 shares 3,268,303 $50.1M 3.07% +104,437 Timeline LBRX LB PHARMACEUTICALS INC More: the full row for LB PHARMACEUTICALS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 1,438,070 shares; 2026Q2: 1,438,070 shares; 2026Q3: 1,509,621 shares 1,509,621 $49.6M 3.04% +71,551 Timeline VRDN VIRIDIAN THERAPEUTICS INC More: the full row for VIRIDIAN THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 2,193,981 shares; 2026Q3: 2,193,981 shares 2,193,981 $45.2M 2.76% 0 Timeline VOR VOR BIOPHARMA INC More: the full row for VOR BIOPHARMA INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 925,067 shares; 2026Q1: 1,925,066 shares; 2026Q2: 1,925,066 shares; 2026Q3: 1,925,066 shares 1,925,066 $36.7M 2.25% 0 Timeline IVA INVENTIVA SA More: the full row for INVENTIVA SA Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 2,000,000 shares; 2026Q1: 4,974,906 shares; 2026Q2: 8,163,191 shares; 2026Q3: 9,185,935 shares 9,185,935 $33.9M 2.07% +1,022,744 Timeline IRD OPUS GENETICS INC More: the full row for OPUS GENETICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 6,075,028 shares; 2026Q2: 6,077,084 shares; 2026Q3: 5,960,972 shares 5,960,972 $28.9M 1.77% -116,112 Timeline AURA AURA BIOSCIENCES INC More: the full row for AURA BIOSCIENCES INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 200,000 shares; 2025Q3: 227,174 shares; 2025Q4: not reported; 2026Q1: 229,864 shares; 2026Q2: 4,298,248 shares; 2026Q3: 4,590,253 shares 4,590,253 $28.8M 1.76% +292,005 Timeline ANIK ANIKA THERAPEUTICS INC More: the full row for ANIKA THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,435,130 shares; 2025Q1: 1,435,130 shares; 2025Q2: 1,435,130 shares; 2025Q3: 1,435,130 shares; 2025Q4: 1,435,130 shares; 2026Q1: 1,435,130 shares; 2026Q2: 1,435,130 shares; 2026Q3: 1,435,130 shares 1,435,130 $28.2M 1.73% 0 Timeline SABS SAB BIOTHERAPEUTICS INC More: the full row for SAB BIOTHERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 7,967,207 shares; 2026Q2: 7,967,207 shares; 2026Q3: 8,736,898 shares 8,736,898 $27.7M 1.69% +769,691 Timeline SGMT SAGIMET BIOSCIENCES INC More: the full row for SAGIMET BIOSCIENCES INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 2,500,000 shares; 2026Q3: 2,794,484 shares 2,794,484 $27.6M 1.69% +294,484 Timeline FTH FAETH THERAPEUTICS INC More: the full row for FAETH THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 126,002 shares; 2026Q2: 629,467 shares; 2026Q3: 890,210 shares 890,210 $26.5M 1.62% +260,743 Timeline TYRA TYRA BIOSCIENCES INC More: the full row for TYRA BIOSCIENCES INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 25,000 shares; 2025Q2: 189,950 shares; 2025Q3: 696,825 shares; 2025Q4: 944,257 shares; 2026Q1: 1,276,968 shares; 2026Q2: 806,986 shares; 2026Q3: 910,749 shares 910,749 $19.9M 1.22% +103,763 Timeline OBX OBSIDIAN THERAPEUTICS INC More: the full row for OBSIDIAN THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 886,281 shares 886,281 $12.2M 0.74% new Timeline EPRX EUPRAXIA PHARMACEUTICALS INC More: the full row for EUPRAXIA PHARMACEUTICALS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 1,163,010 shares 1,163,010 $10.6M 0.65% new Timeline ARTV ARTIVA BIOTHERAPEUTICS INC More: the full row for ARTIVA BIOTHERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 1,736,111 shares; 2026Q3: 1,481,043 shares 1,481,043 $10.5M 0.65% -255,068 Timeline VRCA VERRICA PHARMACEUTICALS INC More: the full row for VERRICA PHARMACEUTICALS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 923,910 shares; 2025Q4: 923,910 shares; 2026Q1: 923,910 shares; 2026Q2: 923,910 shares; 2026Q3: 923,910 shares 923,910 $4.43M 0.27% 0 Timeline TCGX TCGX ACQUISITION CORP More: the full row for TCGX ACQUISITION CORP Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 200,000 shares 200,000 $2.5M 0.15% new Timeline CLRB CELLECTAR BIOSCIENCES INC More: the full row for CELLECTAR BIOSCIENCES INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 469,998 shares; 2026Q3: 469,998 shares 469,998 $865K 0.05% 0 Timeline